208 related articles for article (PubMed ID: 32529761)
1. Prognostic values of the clinicopathological characteristics and survival outcomes in micropapillary urothelial carcinoma of the bladder: A SEER database analysis.
Jin D; Jin K; Qiu S; Zhou X; Yuan Q; Yang L; Wei Q
Cancer Med; 2020 Jul; 9(14):4897-4906. PubMed ID: 32529761
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of micropapillary urothelial carcinoma of the upper urinary tract.
Sung HH; Cho J; Kwon GY; Jeon HG; Jeong BC; Seo SI; Jeon SS; Choi HY; Lee HM
J Clin Pathol; 2014 Jan; 67(1):49-54. PubMed ID: 23940135
[TBL] [Abstract][Full Text] [Related]
3. Micropapillary urothelial carcinoma of urinary bladder displays immunophenotypic features of luminal and p53-like subtypes and is not a variant of adenocarcinoma.
Yang Y; Kaimakliotis HZ; Williamson SR; Koch MO; Huang K; Barboza MP; Zhang S; Wang M; Idrees MT; Grignon DJ; Eble JN; Baldridge LA; Cheng L
Urol Oncol; 2020 May; 38(5):449-458. PubMed ID: 31740332
[TBL] [Abstract][Full Text] [Related]
4. Signet-Ring Cell Carcinoma as an Independent Prognostic Factor for Patients With Urinary Bladder Cancer: A Population-Based Study.
Jin D; Qiu S; Jin K; Zhou X; Cao Q; Yang L; Wei Q
Front Oncol; 2020; 10():653. PubMed ID: 32500022
[No Abstract] [Full Text] [Related]
5. Is Immediate Radical Cystectomy Necessary for All Patients with Non-Muscle-Invasive Micropapillary Bladder Cancer?
Jackson BL; Mohammed A; Mayer N; Dormer J; Griffiths TR
Urol Int; 2016; 96(1):32-8. PubMed ID: 25924623
[TBL] [Abstract][Full Text] [Related]
6. Partial Cystectomy With Pelvic Lymph Node Dissection for Patients With Nonmetastatic Stage pT2-T3 Urothelial Carcinoma of Urinary Bladder: Temporal Trends and Survival Outcomes.
Mistretta FA; Cyr SJ; Luzzago S; Mazzone E; Knipper S; Palumbo C; Tian Z; Nazzani S; Saad F; Montanari E; Tilki D; Briganti A; Shariat SF; de Cobelli O; Karakiewicz PI
Clin Genitourin Cancer; 2020 Apr; 18(2):129-137.e3. PubMed ID: 32001182
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of bladder neck involvement in non-muscle-invasive bladder cancer: A SEER database analysis with 19,919 patients.
Zhan X; Guo J; Chen L; Deng W; Liu X; Zhu K; Liu W; Fu B
Cancer Med; 2021 Oct; 10(19):6868-6880. PubMed ID: 34423585
[TBL] [Abstract][Full Text] [Related]
8. How cancer-specific mortality changes over time after radical cystectomy: Conditional survival of patients with nonmetastatic urothelial carcinoma of the urinary bladder.
Palumbo C; Mistretta FA; Knipper S; Pecoraro A; Tian Z; Shariat SF; Saad F; Simeone C; Briganti A; Antonelli A; Karakiewicz PI
Urol Oncol; 2019 Dec; 37(12):893-899. PubMed ID: 31296422
[TBL] [Abstract][Full Text] [Related]
9. Plasmacytoid Variant Urothelial Carcinoma of the Bladder: A Systematic Review and Meta-Analysis of Clinicopathological Features and Survival Outcomes.
Kim DK; Kim JW; Ro JY; Lee HS; Park JY; Ahn HK; Lee JY; Cho KS
J Urol; 2020 Aug; 204(2):215-223. PubMed ID: 32003614
[TBL] [Abstract][Full Text] [Related]
10. Contemporary use and survival after perioperative systemic chemotherapy in patients with locally advanced non-metastatic urothelial carcinoma of the bladder treated with radical cystectomy.
Mazzone E; Nazzani S; Knipper S; Tian Z; Preisser F; Gallina A; Soulières D; Tilki D; Montorsi F; Shariat SF; Saad F; Briganti A; Wisnivesky J; Karakiewicz PI
Eur J Surg Oncol; 2019 Jul; 45(7):1253-1259. PubMed ID: 30755341
[TBL] [Abstract][Full Text] [Related]
11. More Extensive Lymph Node Dissection Improves Survival Benefit of Radical Cystectomy in Metastatic Urothelial Carcinoma of the Bladder.
Mazzone E; Preisser F; Nazzani S; Tian Z; Fossati N; Gandaglia G; Gallina A; Soulieres D; Tilki D; Montorsi F; Shariat SF; Saad F; Briganti A; Karakiewicz PI
Clin Genitourin Cancer; 2019 Apr; 17(2):105-113.e2. PubMed ID: 30527745
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological implications to micropapillary bladder urothelial carcinoma of the presence of sialyl Lewis X-decorated mucin 1 in stroma-facing membranes.
Shinagawa T; Hoshino H; Taga M; Sakai Y; Imamura Y; Yokoyama O; Kobayashi M
Urol Oncol; 2017 Oct; 35(10):606.e17-606.e23. PubMed ID: 28666720
[TBL] [Abstract][Full Text] [Related]
13. Characterizing the Genomic Landscape of the Micropapillary Subtype of Urothelial Carcinoma of the Bladder Harboring Activating Extracellular Mutations of ERBB2.
Posada JM; Yakirevich E; Kamat AM; Sood A; Jacob JM; Bratslavsky G; Grivas P; Spiess PE; Li R; Necchi A; Mega AE; Golijanin DJ; Pavlick D; Huang RSP; Lin D; Danziger N; Sokol ES; Sivakumar S; Ross JS; Cheng L
Mod Pathol; 2024 Mar; 37(3):100424. PubMed ID: 38219954
[TBL] [Abstract][Full Text] [Related]
14. Micropapillary urothelial carcinoma: evaluation of HER2 status and immunohistochemical characterization of the molecular subtype.
Zinnall U; Weyerer V; Compérat E; Camparo P; Gaisa NT; Knuechel-Clarke R; Perren A; Lugli A; Toma M; Baretton G; Kristiansen G; Wirtz RM; Cheng L; Wullich B; Stoehr R; Hartmann A; Bertz S
Hum Pathol; 2018 Oct; 80():55-64. PubMed ID: 29885409
[TBL] [Abstract][Full Text] [Related]
15. Survival After Partial Cystectomy for Variant Histology Bladder Cancer Compared With Urothelial Carcinoma: A Population-based Study.
Luzzago S; Palumbo C; Rosiello G; Knipper S; Pecoraro A; Deuker M; Mistretta FA; Tian Z; Musi G; Montanari E; Shariat SF; Saad F; Briganti A; de Cobelli O; Karakiewicz PI
Clin Genitourin Cancer; 2020 Apr; 18(2):117-128.e5. PubMed ID: 32035800
[TBL] [Abstract][Full Text] [Related]
16. Micropapillary variant of urothelial carcinoma of the urinary bladder; a clinicopathological and immunohistochemical study.
Samaratunga H; Khoo K
Histopathology; 2004 Jul; 45(1):55-64. PubMed ID: 15228444
[TBL] [Abstract][Full Text] [Related]
17. The effect of radical cystectomy on survival in patients with metastatic urothelial carcinoma of the urinary bladder.
Luzzago S; Palumbo C; Rosiello G; Pecoraro A; Deuker M; Tian Z; Shariat SF; Saad F; de Cobelli O; Karakiewicz PI
J Surg Oncol; 2019 Dec; 120(7):1266-1275. PubMed ID: 31562831
[TBL] [Abstract][Full Text] [Related]
18. Human Epidermal Growth Factor Receptor 2 Overexpression in Micropapillary and Other Variants of Urothelial Carcinoma.
Behzatoğlu K; Yörükoğlu K; Demir H; Bal N
Eur Urol Focus; 2018 Apr; 4(3):399-404. PubMed ID: 28753766
[TBL] [Abstract][Full Text] [Related]
19. Micropapillary Versus Urothelial Carcinoma of the Urinary Bladder: Stage at Presentation and Efficacy of Chemotherapy Across All Stages-A SEER-based Study.
Deuker M; Stolzenbach LF; Collà Ruvolo C; Nocera L; Mansour M; Tian Z; Roos FC; Becker A; Kluth LA; Tilki D; Shariat SF; Saad F; Chun FKH; Karakiewicz PI
Eur Urol Focus; 2021 Nov; 7(6):1332-1338. PubMed ID: 32962961
[TBL] [Abstract][Full Text] [Related]
20. Sociodemographic and survival disparities for histologic variants of bladder cancer.
Jue JS; Koru-Sengul T; Moore KJ; Miao F; Alameddine M; Nahar B; Punnen S; Parekh DJ; Ritch CR; Gonzalgo ML
Can J Urol; 2018 Feb; 25(1):9179-9185. PubMed ID: 29524972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
